TACR1 and osteosarcoma: Additionally, the role of the SP/NK-1R pathway in osteosarcoma is highlighted by studies showing SP to induce osteosarcoma cells to proliferate in a concentration-dependent manner [5,13] These preceding studies highlight NK-1R as being an important, potentially effective and selective therapeutic target for osteosarcoma.